| NCSRX | RTEHX | NCSRX / RTEHX | |
| Total Expense Ratio | 0.61 | 1.16 | 53% |
| Annual Report Gross Expense Ratio | 0.68 | 1.16 | 59% |
| Fund Existence | 11 years | 11 years | - |
| Gain YTD | 0.636 | 0.383 | 166% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 250 | 400,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 540M | 26.7B | 2% |
| Annual Yield % from dividends | 7.93 | 5.86 | 135% |
| Returns for 1 year | 7.00 | 6.36 | 110% |
| Returns for 3 years | 29.31 | 26.21 | 112% |
| Returns for 5 years | 27.87 | 25.37 | 110% |
| Returns for 10 years | 97.80 | 87.18 | 112% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| GRF | 11.06 | N/A | N/A |
| Eagle Capital Growth Fund | |||
| XPAY | 53.37 | -0.27 | -0.50% |
| Roundhill S&P 500 Target 20 Managed Distribution ETF | |||
| RILA | 10.91 | -0.16 | -1.41% |
| Indexperts Gorilla Aggressive Growth ETF | |||
| XTL | 164.41 | -5.54 | -3.26% |
| State Street® SPDR® S&P® Telecom ETF | |||
| ARKG | 29.18 | -1.14 | -3.76% |
| ARK Genomic Revolution ETF | |||